Evidence map›Paper›PMID 31682894›Full record

ArticlePharmacology, biochemistry, and behavior2020

The activity-regulated cytoskeleton-associated protein, Arc/Arg3.1, influences mouse cocaine self-administration.

Rachel D Penrod, Morgane Thomsen, Makoto Taniguchi, Yuhong Guo, Christopher W Cowan, Laura N Smith

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Effect of pharmacological manipulations on Arc function.Current research in pharmacology and drug discovery · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rachel D PenrodDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, United States of America.
Morgane ThomsenDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, United States of America.
Makoto TaniguchiDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, United States of America.
Yuhong GuoDepartment of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX 77807, United States of America; Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, United States of America.
Christopher W CowanDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, United States of America.
Laura N SmithDepartment of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX 77807, United States of America; Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA 02478, United States of America. Electronic address: laura.smith@tamu.edu.
Harvard University · USMcLean Hospital · US

Funding

COCA: Project 4. Neurocircuit Strategy to Decrease Cocaine Cue ReactivityP50DA046373 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2019 to 2023
$9.9M
Role of Class IIa HDAC Target Genes in Opioid and Cocaine AddictionR01DA032708 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI COWAN, CHRISTOPHER W · 2013 to 2022
$3.8M
Transcriptional Mechanisms of Addiction-Related Neural PlasticityR01DA027664 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI COWAN, CHRISTOPHER W · 2011 to 2021
$3.6M
Selective Muscarinic Receptor Ligands as Targets for Cocaine Addiction MedicationR00DA027825 · NIDA · MCLEAN HOSPITAL · PI THOMSEN, MORGANE HERMANN · 2012 to 2014
$710k
Epigenetic mechanimsms in cocaine rewardF32DA036319 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PENROD-MARTIN, RACHEL · 2014 to 2016
$164k
NIDA NIH HHS F32 DA036319NIDA NIH HHS P50 DA046373NIDA NIH HHS R00 DA027825NIDA NIH HHS R01 DA027664NIDA NIH HHS R01 DA032708
6 · The paper itself

Abstract

The activity-regulated cytoskeleton-associated protein (Arc, also known as Arg3.1), an immediate early gene and synaptic regulator, is upregulated following a single cocaine exposure. However, there is not much known regarding Arc/Arg3.1's potential contribution to addiction-relevant behaviors. Despite known learning and memory deficits in contextual fear and water-maze reversal learning tasks, we find that mice lacking Arc/Arg3.1 perform conditioned place preference and operant conditioning involving positive reinforcers (food and cocaine) with little-to-no impairment. However, following normal saline-extinction, wild type (WT) mice show a classic inverted-U dose-response function, while Arc/Arg3.1 knockout (KO) mice fail to adjust their intake across multiple doses. Importantly, Arc/Arg3.1 KO and WT mice behave comparably on an increasing cost task (FR1-FR3; acquisition dose), providing evidence that both groups find cocaine reinforcing. Differences in individuals that drive variations in use patterns and particularly, drug intake levels, are critical as they influence the likelihood of developing dependence. Our data suggest that Arc/Arg3.1 may contribute to addiction as a regulator of drug-taking vulnerability under different drug availability conditions.

Indexed as

AnimalsCocaineConditioning, OperantCytoskeletal ProteinsDopamine Uptake InhibitorsDose-Response Relationship, DrugMaleMiceMice, Inbred C57BLMice, KnockoutNerve Tissue ProteinsSelf Administrationactivity regulated cytoskeletal-associated proteinCocaineCytoskeletal ProteinsDopamine Uptake InhibitorsNerve Tissue ProteinsCocaineDose-responseImmediate early geneIntravenous self-administration

Identifiers

PMID31682894
PMCPMC7202920
OpenAlexW2983698758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.